Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Maftei

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Molecular Pain|October 6, 2018
Multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic painAnna Rita Zuena, Daniela Maftei, Giovanni Sebastiano Alemà, et al.
European Journal of Medicinal Chemistry|May 24, 2014
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonistsCenzo Congiu, Valentina Onnis, Alessandro Deplano, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 29, 2023
Blocking prokineticin receptors attenuates synovitis and joint destruction in collagen-induced arthritisDaniela Impellizzeri, Daniela Maftei, Cinzia Severini, et al.
Biomed Research International|February 17, 2015
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury modelRoberta Lattanzi, Daniela Maftei, Veronica Marconi, et al.
Journal of Neuroinflammation|April 19, 2019
Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathyGiorgia Moschetti, Giada Amodeo, Daniela Maftei, et al.
Plos One|January 6, 2016
Antagonism of the Prokineticin System Prevents and Reverses Allodynia and Inflammation in a Mouse Model of DiabetesMara Castelli, Giada Amodeo, Lucia Negri, et al.
Canadian Journal of Physiology and Pharmacology|October 6, 2021
Serum prokineticin-2 in prepubertal and adult Klinefelter individualsMarco Fiore, Luigi Tarani, Antonio Radicioni, et al.
Cells|November 27, 2019
Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer's Disease: From Animal Models to the Human PathologyRoberta Lattanzi, Daniela Maftei, Carla Petrella, et al.
Neuropharmacology|August 14, 2019
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin systemDaniela Maftei, Patrizia Ratano, Ilaria Fusco, et al.
Journal of Neuroinflammation|May 17, 2021
High-fat diet impairs duodenal barrier function and elicits glia-dependent changes along the gut-brain axis that are required for anxiogenic and depressive-like behaviorsLuisa Seguella, Mirella Pesce, Riccardo Capuano, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Molecular Pain|October 6, 2018
Multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic painAnna Rita Zuena, Daniela Maftei, Giovanni Sebastiano Alemà, et al.
European Journal of Medicinal Chemistry|May 24, 2014
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonistsCenzo Congiu, Valentina Onnis, Alessandro Deplano, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 29, 2023
Blocking prokineticin receptors attenuates synovitis and joint destruction in collagen-induced arthritisDaniela Impellizzeri, Daniela Maftei, Cinzia Severini, et al.
Biomed Research International|February 17, 2015
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury modelRoberta Lattanzi, Daniela Maftei, Veronica Marconi, et al.
Journal of Neuroinflammation|April 19, 2019
Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathyGiorgia Moschetti, Giada Amodeo, Daniela Maftei, et al.
Plos One|January 6, 2016
Antagonism of the Prokineticin System Prevents and Reverses Allodynia and Inflammation in a Mouse Model of DiabetesMara Castelli, Giada Amodeo, Lucia Negri, et al.
Canadian Journal of Physiology and Pharmacology|October 6, 2021
Serum prokineticin-2 in prepubertal and adult Klinefelter individualsMarco Fiore, Luigi Tarani, Antonio Radicioni, et al.
Cells|November 27, 2019
Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer's Disease: From Animal Models to the Human PathologyRoberta Lattanzi, Daniela Maftei, Carla Petrella, et al.
Neuropharmacology|August 14, 2019
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin systemDaniela Maftei, Patrizia Ratano, Ilaria Fusco, et al.
Journal of Neuroinflammation|May 17, 2021
High-fat diet impairs duodenal barrier function and elicits glia-dependent changes along the gut-brain axis that are required for anxiogenic and depressive-like behaviorsLuisa Seguella, Mirella Pesce, Riccardo Capuano, et al.
Pageof 5